The work of Ji et al. demonstrated that HMGB3 binds miR-216a-3p [228], which is a tumor suppressor in colon [196], gastric [197,229], and breast cancers [195], as well as in pancreatic ductal adenocarcinoma [198]. This evidence concerns the gene HMGB3 and breast cancer.